Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FP187 – Oral Immunomodulatory Dimethyl Fumarate (DMF)
Mycophenolate mofetil for relapsing-remitting multiple sclerosis.
Remyelination in experimental models of toxin-induced demyelination.
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls.
Improving the translational hit of experimental treatments in multiple sclerosis.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
TECFIDERA® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis
Positive results from Phase 3 CONFIRM clinical trial show efficacy and safety of oral BG-12 in multiple sclerosis
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.
Zist Daru, ZIFERON
Parenteral Dilantin®
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.
HLA-DRB1*15:01 and multiple sclerosis: a female association?
EAE: an immunologist's magic eye.
Scientific discussion for the approval of Masivet
Recruiting women smokers: the engineering of consent.
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.
Sex ratio of multiple sclerosis and clinical phenotype.
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
Mycophenolate mofetil therapy in the management of inflammatory bowel disease - A retrospective case series and review.
Temporal trends in the incidence of multiple sclerosis: a systematic review.

Pages